Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rachel E Sachs

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
Journal of Health Politics, Policy and Law|June 2, 2021
The Rhetorical Transformations and Policy Failures of Prescription Drug Pricing Reform under the Trump AdministrationRachel E Sachs
The Journal of Legal Medicine|September 11, 2019
Addressing Pharmaceutical Price Spikes Through Generic PreclearanceRachel E Sachs
The New England Journal of Medicine|May 7, 2020
Importing Prescription Drugs from Canada - Legal and Practical Problems with the Trump Administration's ProposalRachel E Sachs, Nicholas Bagley
JAMA|June 24, 2026
CMS' GLP-1 Bridge Demonstration-Questions and Potential ConsequencesRachel E Sachs, Kristi Martin
The New England Journal of Medicine|September 13, 2018
Limiting State Flexibility in Drug PricingNicholas Bagley, Rachel E Sachs
The New England Journal of Medicine|April 13, 2017
An FDA Commissioner for the 21st CenturyAmitabh Chandra, Rachel E Sachs
The New England Journal of Medicine|November 19, 2021
Medicare Coverage of Aducanumab - Implications for State BudgetsRachel E Sachs, Nicholas Bagley
JAMA Health Forum|October 11, 2022
Ensuring Access to Emerging COVID-19 Treatments Through Medicare Reimbursement PolicyRachel E Sachs, Adam Sacarny
The New England Journal of Medicine|March 4, 2022
Step Therapy's Balancing Act - Protecting Patients while Addressing High Drug PricesRachel E Sachs, Michael Anne Kyle
Annals of Internal Medicine|October 11, 2016
Innovation-Innovation Tradeoffs in Drug PricingRachel E Sachs, Austin B Frakt
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Journal of Health Politics, Policy and Law|June 2, 2021
The Rhetorical Transformations and Policy Failures of Prescription Drug Pricing Reform under the Trump AdministrationRachel E Sachs
The Journal of Legal Medicine|September 11, 2019
Addressing Pharmaceutical Price Spikes Through Generic PreclearanceRachel E Sachs
The New England Journal of Medicine|May 7, 2020
Importing Prescription Drugs from Canada - Legal and Practical Problems with the Trump Administration's ProposalRachel E Sachs, Nicholas Bagley
JAMA|June 24, 2026
CMS' GLP-1 Bridge Demonstration-Questions and Potential ConsequencesRachel E Sachs, Kristi Martin
The New England Journal of Medicine|September 13, 2018
Limiting State Flexibility in Drug PricingNicholas Bagley, Rachel E Sachs
The New England Journal of Medicine|April 13, 2017
An FDA Commissioner for the 21st CenturyAmitabh Chandra, Rachel E Sachs
The New England Journal of Medicine|November 19, 2021
Medicare Coverage of Aducanumab - Implications for State BudgetsRachel E Sachs, Nicholas Bagley
JAMA Health Forum|October 11, 2022
Ensuring Access to Emerging COVID-19 Treatments Through Medicare Reimbursement PolicyRachel E Sachs, Adam Sacarny
The New England Journal of Medicine|March 4, 2022
Step Therapy's Balancing Act - Protecting Patients while Addressing High Drug PricesRachel E Sachs, Michael Anne Kyle
Annals of Internal Medicine|October 11, 2016
Innovation-Innovation Tradeoffs in Drug PricingRachel E Sachs, Austin B Frakt
Pageof 4